Oriental Aromatics Limited (OAL) fundamentals
Oriental Aromatics Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as OAL (ISIN INE959C01023). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Oriental Aromatics Limited does
Oriental Aromatics Ltd is an India-based company, which is an integrated manufacturer of flavors, fragrance as well as specialty aroma chemicals. The Company operates through Fine Chemicals segment. Its products include fragrance, flavor, aroma chemicals, and camphor. The Company is a supplier of fine fragrance and perfume raw materials. It manufactures synthetic camphor, which can be utilized in several different ways. Its customers are located in North America, Europe and the Middle East.
Valuation and market data
| Last close | ₹531.30 |
|---|---|
| Market capitalisation | ₹1,795 crore |
| Enterprise value | ₹1,868 crore |
| P/E (TTM) | 542.14 |
| Price to book | 2.70 |
| Price to sales (TTM) | 0.99 |
| Book value per share | ₹196.75 |
| Dividend yield | 9.41% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Thu Jul 11 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,040 crore | ₹11 crore | ₹3 crore | 0.98 |
| Mar 2025 | ₹931 crore | ₹48 crore | ₹34 crore | 10.20 |
| Mar 2024 | ₹844 crore | ₹14 crore | ₹9 crore | 2.71 |
| Mar 2023 | ₹855 crore | ₹27 crore | ₹20 crore | 5.87 |
| Mar 2022 | ₹873 crore | ₹76 crore | ₹53 crore | 15.84 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 74.2% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 25.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.